Skip to main content

Table 3 Disease control and survival with IORT for locally recurrent rectal cancer in association with R0 resection. Results of selected series

From: Intraoperative radiation therapy for colon and rectal cancers: a clinical review

Study

Years

# Patients

EBRT dose, Gy

IORT dose, Gy

IORT technique

5-year LC

5-year DM

5-year OS

Alektiar, MSKCC [30]

1992–1998

53

50.4a

10–18

IOHDR

43%

-

36%

Lindel, MGH [31]

1978–1997

25

50.4b

10–15

IOERT

56%

-

40%

Wiig, Norway [33]

1990–1999

18

46–50

15–20

IOERT

70%

-

60%

Eble, Heidelberg [33] c

1991–1995

14

41.4

10–20

IOERT

79%

19%

71%d

Dresen, Eindhoven [34]

1994–2006

84

50.4e

10

IOERT

69%

34%

48%

Haddock, Mayo Clinic [19]

1981–2008

236

50.4f

12.5

IOERT

79%

48%

46%

  1. Abbreviations: R0 pathologically negative margins, EBRT external beam radiation therapy, IORT intraoperative radiation therapy, LC local control, DM distant metastases, OS overall survival, MSKCC Memorial Sloan Kettering Cancer Center, MGH Massachusetts General Hospital, IOHDR Intraoperative high dose rate brachytherapy
  2. a50.4 in patients with no prior EBRT; no EBRT in patients with prior radiation
  3. b20–50 Gy in previously irradiated patients
  4. c4-year results
  5. d4-year relapse free survival
  6. e30.6 Gy in previously irradiated patients
  7. f5–39.6 Gy in previously irradiated patients